|
EP3737365A1
|
|
Compositions and methods of treating cancer with glycomimetic peptides
|
|
AU2015364559A1
|
|
Immunotherapy treatments and compositions
|
|
US2017290922A1
|
|
Activation of adaptive immune processes for the treatment of cancers and infectious diseases
|
|
WO2016175878A1
|
|
Compositions and methods for treating cancer and persistent viral infections
|
|
US2018140657A1
|
|
Compositions and methods for treating cancer and persistent viral infections
|
|
USRE46425E
|
|
Pro-angiogenic peptides and uses thereof
|
|
US2015299255A1
|
|
Compositions and methods for modulating innate and adaptive immune systems
|
|
US2015299252A1
|
|
Compositions and methods for modulating innate and adaptive immune systems
|
|
US2014155313A1
|
|
Hydrogels with covalently linked polypeptides
|
|
US2008292650A1
|
|
Therapeutic and diagnostic peptides
|
|
US2008233081A1
|
|
Pro-angiogenic peptides
|
